The FRESH Study: An Investigational Drug Trial Seeking Patients with Alcoholic Hepatitis

Clinical Trial Title

The FRESH study: A study evaluating the safety, tolerability, and efficacy of an investigational drug in patients with severe alcohol-associated hepatitis

National Clinical Trial Number:


Contact Information

Clinical Trial Protocol Description:

Study for an investigational drug vs placebo for patients who are in the hospital with severe alcoholic hepatitis. Patients must be willing to travel to Rush's downtown campus for 7-8 follow-up visits once discharged from the hospital.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have a history of excess alcohol use for greater than or equal to 6 months.
  • Have become jaundiced (yellowing of skin) within 8 weeks of hospital admission. 

You will be excluded from the study if any of the following criteria apply to you:

  • Have taken systemic corticosteroids or products containing obeticholic acid in the past 30 days .
  • Have been diagnosed with malignancy within the 2 years prior to Screening.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Study Details

Clinical Trial Investigator

Steven Flamm, MD

Contact Information

Diana Goldman

Clinical Trial Location

RUSH University Medical Center


RUSH University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more